Evidence map›Paper›PMID 40306388›Full record

ArticleJournal of substance use and addiction treatment2025

Perspectives of treatment providers overseeing substance use disorder treatment among transition-age adults, aged 18-25 years.

Josh Aleksanyan, Zobaida Maria, Diego Renteria, Adetayo Fawole, Ashly E Jordan, Vanessa Drury, Sam Kawola, Jamie Del Rosario, Patricia Lincourt, Maria L Morris-Grove and 3 more

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Josh AleksanyanDepartment of Population Health, New York University Grossman School of Medicine, NY, New York, United States.
Zobaida MariaDepartment of Population Health, New York University Grossman School of Medicine, NY, New York, United States.
Diego RenteriaDepartment of Population Health, New York University Grossman School of Medicine, NY, New York, United States.
Adetayo FawoleDepartment of Population Health, New York University Grossman School of Medicine, NY, New York, United States.
Ashly E JordanNew York State Office of Addiction Services and Supports, Albany, New York, United States.
Vanessa DruryNew York State Office of Addiction Services and Supports, Albany, New York, United States.
Sam KawolaNew York State Office of Addiction Services and Supports, Albany, New York, United States.
Jamie Del RosarioNew York State Office of Addiction Services and Supports, Albany, New York, United States.
Patricia LincourtNew York State Office of Addiction Services and Supports, Albany, New York, United States.
Maria L Morris-GroveNew York State Office of Addiction Services and Supports, Albany, New York, United States.
Sueun HongDepartment of Population Health, New York University Grossman School of Medicine, NY, New York, United States.
Sugy ChoiDepartment of Population Health, New York University Grossman School of Medicine, NY, New York, United States.
Charles J NeighborsDepartment of Population Health, New York University Grossman School of Medicine, NY, New York, United States. Electronic address: Charles.neighbors@nyulangone.org.

Funding

Organizational factors associated with quality of care for opioid use disorders among transition-age adults in Medicaid - Revision - Revision - 1 - Diversity SupplementR01DA057267 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHARLES J NEIGHBORS · 2023 to 2026
$3.0M
NIDA NIH HHS R01 DA057267
6 · The paper itself

Abstract

introductionTransition-age (TA) adults, aged 18-25, have the highest prevalence of substance use disorder (SUD) among all age groups yet they are less likely to seek treatment and more likely to discontinue it than older adults, making them a high-priority treatment population. While structural barriers and varying expectations of recovery may affect treatment initiation, insights from providers working with TA adults can reveal what further impels and impedes treatment engagement.

methodsWe conducted two focus groups with 14 front-line treatment providers, representing urban and rural outpatient, residential, and inpatient SUD care settings across New York State. Providers were selected through stratified sampling using restricted-access treatment registry data. A semi-structured interview guide facilitated discussions, and transcripts were analyzed to identify key themes.

resultsProviders report that TA adults prefer briefer, innovative treatment approaches over traditional modalities like A.A./12-step recovery, driven by a desire to rebuild their lives through education and career. Post-pandemic social disruptions were cited as exacerbating engagement challenges and increasing the need for integrating mental health support. Providers highlighted the potential of technology to enhance treatment engagement, though expressed concerns regarding social isolation and the fraying of childhood safety nets and support systems (e.g., housing) undermining successful treatment outcomes and transitions to adulthood more broadly.

conclusionsProviders report and perceive various challenges-unmet mental health needs, social alienation, and housing insecurity-that impede TA adults from successful SUD treatment. Understanding providers' perceptions of the needs of young adults can inform patient and clinical decision-making, lead to the development of innovative treatment approaches tailored to TA adults and contribute to improved health outcomes over the life course.

Indexed as

Attitude of Health PersonnelHealth PersonnelSubstance-Related DisordersTransition to Adult CareAdolescentAdultCOVID-19FemaleFocus GroupsHumansMaleNew YorkQualitative ResearchYoung AdultMental healthSocial developmentSubstance use disorder (SUD)Transition-age adultsTreatment engagement

Identifiers

PMID40306388
PMCPMC12158624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.